Q: Reading a recent Q and A on MGNI I was reminded of APPS which was once viewed positively. It seems TTD is a winner, MGNI I maybe a rebound candidate and that APPS is just dead? Do you see any potential in this as being a high upside play when rates are lower?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Which stock is cheaper on a valuation basis and would produce better growt over medium term. Would you suggest selling ford to buy magna.
Thanks
Thanks
Q: Hi,
Would you have any concerns for CRWD's upcoming earnings report? Given that PANW got hit fairly hard after their recent earnings, I am wondering if we might see something similar on CRWD, and whether or not today's drop is a bit of a heads' up something is about the change? Any thoughts you can offer would be much appreciated!
Thanks,
Dawn
Would you have any concerns for CRWD's upcoming earnings report? Given that PANW got hit fairly hard after their recent earnings, I am wondering if we might see something similar on CRWD, and whether or not today's drop is a bit of a heads' up something is about the change? Any thoughts you can offer would be much appreciated!
Thanks,
Dawn
Q: Prior to earning BKNG has gone up to $3900 a share and on earnings pulled back to around $3500. Is this a good entry point to add to my position or do you have any concerns about the stock for the next 2-3 years? Thanks in advance
Regards,
Brendan
Regards,
Brendan
-
Intuitive Surgical Inc. (ISRG $578.87)
-
AbbVie Inc. (ABBV $231.80)
-
Eli Lilly and Company (LLY $1,109.94)
-
Stryker Corporation (SYK $375.08)
-
UnitedHealth Group Incorporated (DE) (UNH $326.28)
Q: Hi All,
I have a really nice gain shorter term gain on LLY thanks to your recommendation of 125% which is down a little from the high.
Is LLY on the over valued side now and starting to correct? Should I sell it and move into another Healthcare name and if so I'd love a few recommendations. I already own a partial position in UNH and ABBV. I see UNH has dropped and may have some issues with the government should they be stayed away from for now? Thanks for your service.
I have a really nice gain shorter term gain on LLY thanks to your recommendation of 125% which is down a little from the high.
Is LLY on the over valued side now and starting to correct? Should I sell it and move into another Healthcare name and if so I'd love a few recommendations. I already own a partial position in UNH and ABBV. I see UNH has dropped and may have some issues with the government should they be stayed away from for now? Thanks for your service.
-
The Trade Desk Inc. (TTD $39.09)
-
Shake Shack Inc. Class A (SHAK $86.99)
-
Samsara Inc. Class A (IOT $37.45)
Q: Shak and IOT have been recommended on US networks. How would you categorize them up against Trade Desk?
I was thinking back of when I joined 5i at the beginning because of being a mutual fund person and seeing the Sprott Growth Funds managed by Peter as being one of the top mutual funds. When I went to the Money Show I was talking to Peter and I was asking questions that now I would have never asked him due to the knowledge I have gained from 5i. I still ask difficult questions but some of the things I asked in those days are now not difficult for me due to the knowledge gained as a result of being a long member of 5i. Thanks so much.
I was thinking back of when I joined 5i at the beginning because of being a mutual fund person and seeing the Sprott Growth Funds managed by Peter as being one of the top mutual funds. When I went to the Money Show I was talking to Peter and I was asking questions that now I would have never asked him due to the knowledge I have gained from 5i. I still ask difficult questions but some of the things I asked in those days are now not difficult for me due to the knowledge gained as a result of being a long member of 5i. Thanks so much.
Q: Hi 5i,
How do you feel about Aurinia, hey will be cashflow positive soon. Recently they announced a 150 million buy back with a 25% staff reduction. They are also ending a strategic review. Sales are ramping up looks like a timely buy with share price at a low. Your thoughts are appreciated.
How do you feel about Aurinia, hey will be cashflow positive soon. Recently they announced a 150 million buy back with a 25% staff reduction. They are also ending a strategic review. Sales are ramping up looks like a timely buy with share price at a low. Your thoughts are appreciated.
Q: How good is Nvidia’s moat to its broader sales clientele, and to what degree could competition or demand fatigue place its top and bottom lines, and by virtue its multiples and stock price, at risk of slow down and potential downside?
-
Bird Construction Inc. (BDT $26.05)
-
Crocs Inc. (CROX $83.07)
-
e.l.f. Beauty Inc. (ELF $72.11)
-
Celsius Holdings Inc. (CELH $40.40)
Q: Good Day,
After your response to my last question, I have deliberating between CELH and CROX (one of your recommendations to expand my portfolio), as well as ELF (come up a lot Lately in the questions).
For your other recommendations of PSTG CRWD DDOG and PLTR, I do like their fundamentals AND their businesses. However, between what I hold already, and the business they're in, I'm worried that in a period when I'm focusing less on the markets, a major player in their space may offer a major, well polished, competitive product. For example, EMC, Hitachi, Oracle, etc could announce something that would slow/change the outlook on PSTG, and I could miss out on locking in some gains.
Also, I've noticed BDT is constantly hitting new highs. I've owned them here and there a few years back, but they've been killing it since then it appears.
So, with all that in mind, and the portfolio from my previous question, and the fact that CELH blew up yesterday (I got busy and didn't get to make my move when you responded earlier this week :( ). Which 2out of CELH, CROX, ELF, and BDT would you suggest? What inning in a baseball game would they be in their lifecycle, their risk, and growth potential, for each of these 4 options.
Thanks!! The last 6 weeks have been huge for me thanks to your help! Might have even shaved a year off my retirement age, so I'm incredibly happy with your service.
After your response to my last question, I have deliberating between CELH and CROX (one of your recommendations to expand my portfolio), as well as ELF (come up a lot Lately in the questions).
For your other recommendations of PSTG CRWD DDOG and PLTR, I do like their fundamentals AND their businesses. However, between what I hold already, and the business they're in, I'm worried that in a period when I'm focusing less on the markets, a major player in their space may offer a major, well polished, competitive product. For example, EMC, Hitachi, Oracle, etc could announce something that would slow/change the outlook on PSTG, and I could miss out on locking in some gains.
Also, I've noticed BDT is constantly hitting new highs. I've owned them here and there a few years back, but they've been killing it since then it appears.
So, with all that in mind, and the portfolio from my previous question, and the fact that CELH blew up yesterday (I got busy and didn't get to make my move when you responded earlier this week :( ). Which 2out of CELH, CROX, ELF, and BDT would you suggest? What inning in a baseball game would they be in their lifecycle, their risk, and growth potential, for each of these 4 options.
Thanks!! The last 6 weeks have been huge for me thanks to your help! Might have even shaved a year off my retirement age, so I'm incredibly happy with your service.
Q: Could you please comment on quarterly results and your outlook for the company moving forward?
-
State Street SPDR S&P Semiconductor ETF (XSD $310.55)
-
VanEck Vectors Semiconductor ETF (SMH $340.01)
Q: Is there any ETF that holds semiconductors equally instead of SMH? SMH holds 1/4 in Nvdia.
Thanks for the great service
Thanks for the great service
Q: Dell was up 30% today. But I read the PE as only 16. Of course, that was likely before the raise. Would you buy into it now as a relatively solid, stable, but growing tech company?
Q: Hi 5i
After the very fast run up in share price what is the current short interest and would you consider it at a level investors should be paying attention to?
Is it in a possible short squeeze position.... if so, is there any position management required in your opinion , or let it ride,,,
Small position since before the split last year but time frame is now only about two years...
Thx
After the very fast run up in share price what is the current short interest and would you consider it at a level investors should be paying attention to?
Is it in a possible short squeeze position.... if so, is there any position management required in your opinion , or let it ride,,,
Small position since before the split last year but time frame is now only about two years...
Thx
Q: Hi 5i, according to my math Goog is trading at 19.6 FY24 and 17.2 FY25 pe's. At what point do you consider this too irresistible? I put on a half position a few months back and looking to bring it upto a full position. I know you guys ❤️ momentum, but there seems to be a new floor daily. Thx.
Q: Can I please have your thoughts about this company’s future and overall prospects?
Thanks
Thanks
Q: I'm letting my winners run right now - while monitoring for news and quality. SMCI took a big jump today because of its promotion. Is a 25% jump warranted here? Thanks!
Q: Interest is peaked when you mentioned this company Arch Capital Group Ltd among CSU LMN TOI HEI TVK as potential long term compounders to Peter's recent question. I haven't heard of the company and the few questions on it here don't give much. I know they are in Insurance, Reinsurance and Mortgage and seems like they have made some decent acquisitions. Performance is inline with Fairfax the last 5 years.
But what reasons made you choose it with the other companies listed TOI, LMN HEI TVK?
Also what stands out vs others in Insurance companies such as Fairfax and Intact in Canada or Markel in USA? DO you prefer it or them or others for GROWTH?
PS did you get a question regarding Bird Construction Group I sent one in Monday, thanks!
But what reasons made you choose it with the other companies listed TOI, LMN HEI TVK?
Also what stands out vs others in Insurance companies such as Fairfax and Intact in Canada or Markel in USA? DO you prefer it or them or others for GROWTH?
PS did you get a question regarding Bird Construction Group I sent one in Monday, thanks!
Q: Thoughts on the quarter and outlook? Is the initiation of the dividend a way to offset slower growth and keep shareholders happy?
-
CVS Health Corporation (CVS $78.47)
-
Eli Lilly and Company (LLY $1,109.94)
-
Stryker Corporation (SYK $375.08)
-
GE HealthCare Technologies Inc. (GEHC $79.96)
Q: I own LLY and GEHC and am looking to add CVS or SYK? I'm actually open to selling LLY or GECH, but my point is I'd like to keep 3.
Please let me know your thoughts.
Please let me know your thoughts.
-
Apple Inc. (AAPL $276.97)
-
Intuitive Surgical Inc. (ISRG $578.87)
-
Axon Enterprise Inc. (AXON $528.89)
Q: ISRG and AXON. Love the narrative and the respective charts for both these stocks. I just can't get past the valuation. For instance, in a recent article on SA by a highly
respected author, he opened my eyes on P/S ratios. Here's a quote:
"While 41 companies in the S&P 500 are trading above 10x price-to-sales, 131 companies (26% of the S&P) trade above 5x sales and must grow sales by more than 100% yearly to maintain that valuation. The problem is that some companies, like Apple (AAPL), have declining revenue growth rates."
Both ISRG and AXON are in this high P/S category he's referring to. In fact not only are they both above 5, they are above 10. Were they priced at more reasonable P/S levels during the last recession? Is that the only time you can grab these two wide-moat companies at a more compelling ratio?
respected author, he opened my eyes on P/S ratios. Here's a quote:
"While 41 companies in the S&P 500 are trading above 10x price-to-sales, 131 companies (26% of the S&P) trade above 5x sales and must grow sales by more than 100% yearly to maintain that valuation. The problem is that some companies, like Apple (AAPL), have declining revenue growth rates."
Both ISRG and AXON are in this high P/S category he's referring to. In fact not only are they both above 5, they are above 10. Were they priced at more reasonable P/S levels during the last recession? Is that the only time you can grab these two wide-moat companies at a more compelling ratio?